245 related articles for article (PubMed ID: 21059087)
1. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes.
Cherney DZ; Sochett EB; Dekker MG; Perkins BA
Diabet Med; 2010 Dec; 27(12):1358-65. PubMed ID: 21059087
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cystatin C- and creatinine-based estimation of glomerular filtration rate according to glycaemic status in Type 2 diabetes.
Oh SJ; Lee JI; Ha WC; Jeong SH; Yim HW; Son HS; Sohn TS
Diabet Med; 2012 Jul; 29(7):e121-5. PubMed ID: 22414167
[TBL] [Abstract][Full Text] [Related]
3. Ability of Cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes.
Perkins BA; Sochett EB; Cherney DZ
Clin Exp Hypertens; 2012; 34(8):606-11. PubMed ID: 22686422
[TBL] [Abstract][Full Text] [Related]
4. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.
Mueller TF; Raeder J; Oettl K; Zitta S; Klausmann G; Estelberger W; Luyckx VA; Reibnegger G
Ren Fail; 2008; 30(1):21-9. PubMed ID: 18197539
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
[TBL] [Abstract][Full Text] [Related]
7. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
Hoek FJ; Kemperman FA; Krediet RT
Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.
Rigalleau V; Beauvieux MC; Le Moigne F; Lasseur C; Chauveau P; Raffaitin C; Perlemoine C; Barthe N; Combe C; Gin H
Diabetes Metab; 2008 Nov; 34(5):482-9. PubMed ID: 18703370
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
Li HX; Xu GB; Wang XJ; Zhang XC; Yang JM
Chin Med J (Engl); 2010 Mar; 123(6):745-51. PubMed ID: 20368098
[TBL] [Abstract][Full Text] [Related]
10. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
Peczyńska J; Urban M; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
[TBL] [Abstract][Full Text] [Related]
11. Is cystatin C a useful marker in the detection of diabetic kidney disease?
Borges RL; Hirota AH; Quinto BM; Ribeiro AB; Zanella MT; Batista MC
Nephron Clin Pract; 2010; 114(2):c127-34. PubMed ID: 19887833
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
[TBL] [Abstract][Full Text] [Related]
13. Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate.
Sterner G; Björk J; Carlson J; Grubb A; Nyman U
Scand J Urol Nephrol; 2009; 43(3):242-9. PubMed ID: 19291590
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella N; George S
Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
[TBL] [Abstract][Full Text] [Related]
15. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
Lee BW; Ihm SH; Choi MG; Yoo HJ
Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C and blood pressure: results of 24 h ambulatory blood pressure monitoring.
Mena C; Robles NR; de Prado JM; Gallego FG; Cidoncha A
Eur J Intern Med; 2010 Jun; 21(3):185-90. PubMed ID: 20493420
[TBL] [Abstract][Full Text] [Related]
17. Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes.
Maahs DM; Ogden LG; Kretowski A; Snell-Bergeon JK; Kinney GL; Berl T; Rewers M
Diabetes; 2007 Nov; 56(11):2774-9. PubMed ID: 17660266
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C-based equations in renal transplantation: moving toward a better glomerular filtration rate prediction?
Maillard N; Mariat C; Bonneau C; Mehdi M; Thibaudin L; Laporte S; Alamartine E; Chamson A; Berthoux F
Transplantation; 2008 Jun; 85(12):1855-8. PubMed ID: 18580481
[TBL] [Abstract][Full Text] [Related]
20. Serum cystatin C versus serum creatinine in the estimation of glomerular filtration rate in rhabdomyolysis.
Yap M; Lamarche J; Peguero A; Courville C
J Ren Care; 2011 Sep; 37(3):155-7. PubMed ID: 21810197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
